Sunniva (XCNQ:SNN) Gross-Profit-to-Asset % : 4.66% (As of Sep. 2019)

View and export this data going back to 2018. Start your Free Trial

What is Sunniva Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Sunniva's annualized Gross Profit for the quarter that ended in Sep. 2019 was C$6.29 Mil. Sunniva's average Total Assets over the quarter that ended in Sep. 2019 was C$134.93 Mil. Therefore, Sunniva's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2019 was 4.66%.

Sunniva Gross-Profit-to-Asset % Historical Data

The historical data trend for Sunniva's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunniva Gross-Profit-to-Asset % Chart

Sunniva Annual Data

Trend

Dec16

Dec17

Dec18

Gross-Profit-to-Asset %

0.10

13.29

7.79

Sunniva Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Gross-Profit-to-Asset %	Get a 7-Day Free Trial								0.85	24.78	15.45	2.19	4.66

Competitive Comparison of Sunniva's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Sunniva's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunniva's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunniva's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Sunniva's Gross-Profit-to-Asset % falls into.

Sunniva Gross-Profit-to-Asset % Calculation

Sunniva's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2018 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2018 )	/	( (Total Assets (A: Dec. 2017 )	+	Total Assets (A: Dec. 2018 ))	/ count )
	=	7.799	/	( (74.907	+	125.32)	/ 2 )
	=	7.799	/	100.1135
	=	7.79 %

Sunniva's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2019 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Sep. 2019 )	/	( (Total Assets (Q: Jun. 2019 )	+	Total Assets (Q: Sep. 2019 ))	/ count )
	=	6.292	/	( (139.974	+	129.886)	/ 2 )
	=	6.292	/	134.93
	=	4.66 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2019) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Sunniva Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Sunniva's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunniva Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunniva Inc (XCNQ:SNN) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Burrard Street, 1200 Waterfront Centre, P.O Box 48600, Vancouver, BC, CAN, V7X 1T2

Website

https://www.sunniva.com

Sunniva Inc is vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. The company is focused on the cultivation, production and distribution of therapeutic solutions targeting two of the medical cannabis markets in the world: Canada and California.

Executives

Mark Hamish Kimmins

Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)